Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis

Cipriani, Andrea, Furukawa, Toshi A, Salanti, Georgia, Chaimani, Anna, Atkinson, Lauren Z, Ogawa, Yusuke, Leucht, Stefan, Ruhe, Henricus G +10 more·2018·Focus
DOI 10.1176/appi.focus.16407

Cited by (330)

Items 101–200 of 330

  1. Therapeutic dose assessment of patient switching from atorvastatin to simvastatin.
    Gregory P. Hess, Kafi N. Sanders, Jerrold W. Hill, Larry Z. Liu · 2007 · PubMed
  2. Depressive disorder and antidepressants from an epigenetic point of view
    Iris Šalamon Arčan, Katarina Kouter, Alja Videtič Paska · 2022 · World Journal of Psychiatry
  3. Psychedelic Therapy vs Antidepressants for the Treatment of Depression Under Equal Unblinding Conditions
    Zachary J. Williams, Hannah Barnett, Balázs Szigeti · 2026 · JAMA Psychiatry
  4. Temporal derivative computation in the dorsal raphe network revealed by an experimentally driven augmented integrate-and-fire modeling framework
    Emerson F. Harkin, Michael B. Lynn, Alexandre Payeur, Jean-François Boucher, Léa Caya-Bissonnette, Dominic Cyr, Chloe A. Stewart, André Longtin, Richard Naud, Jean-Claude Béïque · 2023 · eLife
  5. The protective role of melatonin in citalopram-induced reproductive toxicity via modulating nitro-oxidative stress and apoptosis in male mice
    Mojtaba Moradi, Mohammad Arshia Hashemian, Erfan Douhandeh, Mohsen Peysokhan, Amir Hossein Hashemian, Azita Faramarzi · 2023 · Reproductive Toxicology
  6. Individual Deviations from Normative Electroencephalographic Connectivity Predict Antidepressant Response
    Xiaoyu Tong, Hua Xie, Wei Wu, Corey J. Keller, Gregory A. Fonzo, Matthieu Chidharom, Nancy Beth Carlisle, Amit Etkin, Yu Zhang · 2023 · Journal of Affective Disorders
  7. The Increasing Economic Burden with Additional Steps of Pharmacotherapy in Major Depressive Disorder
    Alix M. Arnaud, Ellison Dial Suthoff, Rita M. Tavares, Xuan Zhang, Aditi J. Ravindranath · 2021 · PharmacoEconomics
  8. Antidepressive Effects of Taraxacum Officinale in a Mouse Model of Depression Are Due to Inhibition of Corticosterone Levels and Modulation of Mitogen-Activated Protein Kinase Phosphatase-1 (Mkp-1) and Brain-Derived Neurotrophic Factor (Bdnf) Expression
    Cunyou Gao, Suli Kong, Benyu Guo, Xuejun Liang, Hui-feng Duan, Donghe Li · 2019 · Medical Science Monitor
  9. Evaluation of behavioural and neurochemical effects of psilocybin in mice subjected to chronic unpredictable mild stress
    Ines Erkizia-Santamaría, Igor Horrillo, Nerea Martínez-Álvarez, Daniel Pérez-Martínez, Guadalupe Rivero, Amaia Maite Erdozain, J. Javier Meana, Jorge Emilio Ortega · 2025 · Translational Psychiatry
  10. Use of Acute Psychiatric Hospitalisation: A Study of the Factors Influencing Decisions to Arrange Acute Admission to Inpatient Mental Health Facilities
    Rajan Nathan, Mark Gabbay, Sean Boyle, Phil Elliott, Clarissa Marie Giebel, Carl O'Loughlin, Pete Wilson, Pooja Saini · 2021 · Frontiers in Psychiatry
  11. Choosing an antidepressant
    Philip M. Boyce, Cassandra Ma · 2021 · Australian Prescriber
  12. Predicting non-response to multimodal day clinic treatment in severely impaired depressed patients: a machine learning approach
    Johannes Vetter, Katharina Schultebraucks, Isaac R. Galatzer‐Levy, Heinz Boeker, Annette Beatrix Brühl, Erich Seifritz, Birgit Kleim · 2022 · Scientific Reports
  13. Availability of two essential medicines for mental health in Bangladesh, the Democratic Republic of Congo, Haiti, Nepal, Malawi, Senegal, and Tanzania: Evidence from nationally representative samples of 7958 health facilities
    Muhammad Rahman, Yusuf Babaye, Amritha S Bhat, Pamela Y. Collins, Christopher G. Kemp · 2022 · Journal of Global Health
  14. The effect of SSRIs on Semen quality: A systematic review and meta-analysis
    Jiarong Xu, Kancheng He, Yihong Zhou, Liangyu Zhao, Yuteng Lin, Zihao Huang, Nengqing Xie, Jihui Yue, Yuxin Tang · 2022 · Frontiers in Pharmacology
  15. Altered fronto-central theta-gamma coupling in major depressive disorder during auditory steady-state responses
    Wenquan Zhang, Wei Liu, Shuang Liu, Fangyue Su, Xianyun Kang, Yufeng Ke, Dong Ming · 2022 · Clinical Neurophysiology
  16. Using Machine Learning to Predict Antidepressant Treatment Outcome From Electronic Health Records
    Zhenxing Xu, Veer Vekaria, Fei Wang, Judith Cukor, Chang Su, Prakash M. Adekkanattu, Pascal Brandt, Guoqian Jiang, Richard C. Kiefer, Yuan Luo et al. · 2023 · Psychiatric Research and Clinical Practice
  17. Exploring the Association between Anxiety, Depression, and Gut Microbiota during Pregnancy: Findings from a Pregnancy Cohort Study in Shijiazhuang, Hebei Province, China
    Ruixin Chi, Muxia Li, Man Zhang, Na Zhang, Guohua Zhang, Lijun Cui, Guansheng Ma · 2024 · Nutrients
  18. Altered synaptic homeostasis: a key factor in the pathophysiology of depression
    Bokai Wang, Teng He, Guofan Qiu, Chong Li, Song Xue, Yuanjia Zheng, Taiyi Wang, Yucen Xia, Lin Yao, Jinglan Yan et al. · 2025 · Cell & Bioscience
  19. Lost Evidence From Registered Large Long-Unpublished Randomized Controlled Trials: A Survey
    Athina Tatsioni, Fotini B. Karassa, Steven N. Goodman, Deborah A. Zarin, Daniele Fanelli, John P. A. Ioannidis · 2019 · Annals of Internal Medicine
  20. Antidepressant efficacy of Agomelatine: Meta-analysis of placebo controlled and active comparator studies
    Raghava Kalyan Maddukuri, Chava Hema, Kondaveeti Sri Tejaswi, Mutthineni Venkata Mounika, Bindu Priyanka Vegesana · 2021 · Asian Journal of Psychiatry
  21. Impact of Insomnia Symptoms on the Clinical Presentation of Depressive Symptoms: A Cross-Sectional Population Study
    Yun Ho Choi, Kwang Ik Yang, Chang‐Ho Yun, Won‐Joo Kim, Kyoung Heo, Min Kyung Chu · 2021 · Frontiers in Neurology
  22. Sclareol exerts synergistic antidepressant effects with quercetin and caffeine, possibly suppressing GABAergic transmission in chicks
    Hossam Mohammed Kamli, Ahmad A. Shaikh, Mehedi Hasan Bappi, António Raposo, Md Faruque Ahmad, Fatema Akter Sonia, Md. Showkoth Akbor, Abdullah Al Shamsh Prottay, Sheila Alves Gonçalves, Isaac Moura Araújo et al. · 2023 · Biomedicine & Pharmacotherapy
  23. Electroconvulsive Shock, but Not Transcranial Magnetic Stimulation, Transiently Elevates Cell Proliferation in the Adult Mouse Hippocampus
    Tian Rui Zhang, Evelyn Maria Guilherme, Aydan Kesici, Alyssa M. Ash, Fidel Vila‐Rodriguez, Jason S. Snyder · 2021 · Cells
  24. Influence of antidepressant treatment on SLC6A4 methylation in Korean patients with major depression
    Young Kyung Moon, Hye Seung Kim, Seonwoo Kim, Shinn‐Won Lim, Doh Kwan Kim · 2022 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
  25. Course of Subtypes of Late-Life Depression Identified by Bipartite Network Analysis During Psychosocial Interventions
    Nili Solomonov, Jihui Lee, Samprit Banerjee, Serena Z. Chen, Jo Anne Sirey, Faith M. Gunning, Conor M. Liston, Patrick J. Raue, Patricia A. Areán, George S. Alexopoulos · 2023 · JAMA Psychiatry
  26. Treatments for partial remission of major depressive disorder: a systematic review and meta-analysis
    Joost Gülpen, Marlies E. Brouwer, Gert J. Geurtsen, Eva A.M. van Dis, Damiaan A J P Denys, Claudi Bockting · 2023 · BMJ Mental Health
  27. Comparative Efficacy of Animal Depression Models and Antidepressant Treatment: A Systematic Review and Meta-Analysis
    Piotr Ratajczak, Jakub Martyński, Jan Kazimierz Zięba, Katarzyna Świło, Dorota Kopciuch, Anna Paczkowska, Tomasz Zaprutko, Krzysztof Kus · 2024 · Pharmaceutics
  28. Evolution of Heart Rate Variability and Heart Rate Turbulence in Patients with Depressive Illness Treated with Selective Serotonin Reuptake Inhibitors
    Cătălina Giurgi-Oncu, Cristina Tudoran, VIRGIL RADU ENĂTESCU, Mariana Tudoran, Gheorghe Nicușor Pop, Cristina Ana Bredicean · 2020 · Medicina
  29. Cannabinoid Receptor 2 Blockade Prevents Anti-Depressive-like Effect of Cannabidiol Acid Methyl Ester in Female WKY Rats
    Danielle Hen-Shoval, Lital Moshe, Talia Indig-Naimer, Raphael Mechoulam, Gal Shoval, Gil Zalsman, Natalya M. Kogan, Aron Weller · 2023 · International Journal of Molecular Sciences
  30. l-theanine adjunct to sertraline for major depressive disorder: A randomized, double-blind, placebo-controlled clinical trial
    Ahmad Shamabadi, Farnaz Kafi, Melika Arab Bafrani, Hassan Asadigandomani, Fatemeh A. Basti, Shahin Akhondzadeh · 2023 · Journal of Affective Disorders
  31. Natural psychedelics in the treatment of depression; a review focusing on neurotransmitters
    Samane Jahanabadi, Shayan Amiri, Mehdi Karkeh-abadi, Ali Razmi · 2023 · Fitoterapia
  32. Association of Redlining and Natural Environment with Depressive Symptoms in Women in the Sister Study
    Wei-Lun Tsai, Maliha S. Nash, Daniel J. Rosenbaum, Steven E. Prince, Aimee A. D’Aloisio, Megan H. Mehaffey, Dale P. Sandler, Timothy J. Buckley, Anne Neale · 2023 · Environmental Health Perspectives
  33. Vagus Nerve Stimulation For Treatment Resistant Depression: Case Series Of Six Patients - Retrospective Efficacy And Safety Observation After One Year Follow Up
    K. Kucia, W. Merk, K. Zapałowicz, T. Mędrala · 2019 · Neuropsychiatric Disease and Treatment
  34. General antidepressants prescribing trends 2009–2018 in Slovenia: a cross-sectional retrospective database study
    Nanča Čebron Lipovec, Andrej Anderlic, Igor Locatelli · 2022 · International Journal of Psychiatry in Clinical Practice
  35. Metformin Enhances Antidepressant/Antipsychotic Combination Therapy of Schizophrenia With Comorbid Depression in a Murine Model
    Chunhua Zhou, Dezhi Kong, Rong Xue, Min Chen, Gongying Li, Yong Ji Xu, Sha Liu, Hongjun Tian, Chuanjun Zhuo · 2020 · Frontiers in Neuroscience
  36. A retrospective chart review study to quantify the monthly medical resource use and costs of treating patients with treatment resistant depression in the United Kingdom
    Denee, Tom, Ming, Timothy, Waller, John, Bailey, Tom, Rajkovic-Hooley, Olivera, Middleton-Dalby, Chloe, Le, Hoa H., Zhang, Qiaoyi, McCrone, Paul, Taylor, David · 2021 · Current Medical Research and Opinion
  37. Neuromodulators in the Brain-Gut Axis: their Role in the Therapy of the Irritable Bowel Syndrome
    Mihaela Fadgyas Stănculete, Dan Lucian Dumitrascu, Douglas A. Drossman · 2021 · Journal of Gastrointestinal and Liver Diseases
  38. New perspective on sustained antidepressant effect: focus on neurexins regulating synaptic plasticity
    Yuan Ruan, Ruolan Yuan, Jiaqi He, Yutong Jiang, Shifeng Chu, Nai‐Hong Chen · 2024 · Cell Death Discovery
  39. Expert recommendations for Germany’s integration of psychedelic-assisted therapy
    Sergio Pérez Rosal, Joseph T. La Torre, Susanne Birnkammer, Olga Chernoloz, Monnica T. Williams, Sonya C. Faber · 2024 · BMC Medical Education
  40. Genetic risk for chronic pain is associated with lower antidepressant effectiveness: Converging evidence for a depression subtype
    Adrián I. Campos, Trung Thành Ngô, Sarah Elizabeth Medland, Naomi R. Wray, Ian Bernard Hickie, Enda M. Byrne, Nicholas G. Martin, Miguel E. Rentería · 2021 · Australian & New Zealand Journal of Psychiatry
  41. The Bidirectional Link between Major Depressive Disorder and Type 2 Diabetes: The Role of Inflammation
    Alexandra Maria Bodnaruc, Mathilde Roberge, Isabelle Giroux, Céline Aguer · 2024 · Endocrines
  42. Sociodemographic, clinical, and genetic factors associated with self-reported antidepressant response outcomes in the UK Biobank
    Michelle Kamp, Chris Wai Hang Lo, Grigorios Kokkinidis, Mimansa Chauhan, Alexandra C. Gillett, Andrew Mark McIntosh, Oliver Pain, Cathryn M. Lewis · 2025 · Psychological Medicine
  43. Getting active through mindfulness: Randomised controlled trial of a digital mindfulness-based intervention promoting physical activity engagement and enjoyment
    Masha Remskar, Ben Ainsworth, Olivia Maynard, Olivia S. Malkowski, Adam Birch, Amber Burd, Teodor-Cristian Caretu, Lana El Assaad, Alexia Christodoulou-Tsiaoukkas, Aarya Menon et al. · 2025 · Mental health and physical activity
  44. Whole Body Cryotherapy and Hyperbaric Oxygen Treatment: New Biological Treatment of Depression? A Systematic Review
    Marek Krzystanek, Monika Romańczyk, Stanisław Surma, Agnieszka Koźmin-Burzyńska · 2021 · Pharmaceuticals
  45. Computer‐delivered behavioural activation and approach‐avoidance training in major depression: Proof of concept and initial outcomes
    Alison M. Sweet, Sarah L. Pearlstein, Martin P. Paulus, Murray B. Stein, Charles T. Taylor · 2021 · British Journal of Clinical Psychology
  46. β-carboline-independent antidepressant-like effect of the standardized extract of the barks of Mimosa tenuiflora (Willd) Poir. occurs via 5-HT 2A/2C receptors in mice
    Luiz Antonio Miranda de Souza Duarte Filho, Isabela Araújo e Amariz, Rodolfo Hideki Vicente Nishimura, Ana Beatriz Rodrigues Massaranduba, Pedro Modesto Nascimento Menezes, Tauana Araújo Damasceno, Ivani Brys, Larissa Araújo Rolim, Fabrício Souza Silva, Luciano Augusto de Araújo Ribeiro · 2022 · Journal of Psychopharmacology
  47. Plasma levels of IL-6 in patients with untreated major depressive disorder: comparison with catecholamine metabolites
    Reiji Yoshimura, Taro Kishi, Nakao Iwata · 2019 · Neuropsychiatric Disease and Treatment
  48. Deceptive and open-label placebo effects in experimentally induced guilt: a randomized controlled trial in healthy subjects
    Dilan Sezer, C. Locher, J. Gaab · 2022 · Scientific Reports
  49. Evaluating Clinical Outcomes in Patients Being Treated Exclusively via Telepsychiatry: Retrospective Data Analysis
    2023
  50. Feasibility and acceptability of an integrated mind-body intervention for depression: whole-body hyperthermia (WBH) and cognitive behavioral therapy (CBT)
    Ashley E. Mason, Anoushka Chowdhary, Wendy Hartogensis, Chelsea J. Siwik, Osnat Lupesko-Persky, Leena S. Pandya, Stefanie Roberts, Claudine Anglo, Patricia J. Moran, James Craig Nelson et al. · 2024 · International Journal of Hyperthermia
  51. Natural products that alleviate depression: The putative role of autophagy
    Yunfeng Zhou, Fengwei Nan, Qianwen Zhang, Wangjun Xu, Shaojie Fang, Ke Liu, Bingxin Zhao, Hao Han, Xinmei Xie, Changjiang Qin et al. · 2024 · Pharmacology & Therapeutics
  52. Making a good mental health diagnosis: Science, art and ethics
    Louise Stone, Elizabeth A. Waldron, Heather Nowak · 2020 · Australian Journal of General Practice
  53. Symptom Cluster-Matching Antidepressant Treatment: A Case Series Pilot Study
    Sławomir Murawiec, Marek Krzystanek · 2021 · Pharmaceuticals
  54. About the causes and therapy of depressive disorders in COVID-19
    E.Y. Abritalin · 2021 · S S Korsakov Journal of Neurology and Psychiatry
  55. Network Pharmacology and Experimental Validation to Investigate the Antidepressant Potential of Atractylodes lancea (Thunb.) DC.
    Ly Thi Huong Nguyen, Nhi Phuc Khanh Nguyen, Khoa Nguyen Tran, Heung‐Mook Shin, In‐Jun Yang · 2022 · Life
  56. Reversing anxiety by targeting a stress-responsive signaling pathway
    Saurabh Pandey, Wenyan Han, Jun Li, Ryan David Shepard, Kunwei Wu, David Castellano, Qingjun Tian, Lijin Dong, Yan Li, Wei Lü · 2024 · Proceedings of the National Academy of Sciences
  57. Antidepressant-Like Effect of Essential Oils From Citrus reticulata in Reserpine-Induced Depressive Mouse
    Minghui Tang, Yong Ai, Siyang Zhu, Ni Song, Xian Xu, Leyi Liang, Baoshan Rong, Xiaomin Zheng, Lanyue Zhang, Tinggang He · 2022 · Natural Product Communications
  58. Correlation analysis between physical activity and depressive tendencies among occupational groups: an isotemporal substitution approach
    Yihua Liu, Haoxiang Lin, Hao Zhang, Xiaoyue Zhang, Shengli Yin · 2023 · BMC Public Health
  59. Systematic evaluation of the ‘efficacy‐effectiveness gap’ in the treatment of depression with venlafaxine and duloxetine
    Carolin Schneider, Johanna Breilmann, Benedikt Reuter, Thomas M Becker, Markus Kösters · 2021 · Acta Psychiatrica Scandinavica
  60. The positioning of rTMS
    Gin Singh Malhi, Erica Bell, Greg Murray, Philip M. Boyce, Bill Lyndon, Darryl L. Bassett, Roger Mulder, Malcolm Hopwood, Richard Porter, Ajeet Singh · 2021 · Australian & New Zealand Journal of Psychiatry
  61. Cognitive Behavioral Therapy, Ketamine, and Combination Treatment for Depression: Impressions of Credibility in Participants with Self-Reported Depressive Symptoms
    Earleywine, Mitch, Altman, Brianna R., De Leo, Joseph · 2022 · Journal of Psychoactive Drugs
  62. New insights into the involvement of serotonin and BDNF-TrkB signalling in cannabidiol's antidepressant effect
    Matti Bock Guldager, Caroline Biojone, Nicole Rodrigues da Silva, Lívea Dornela Godoy, Sâmia R.L. Joca · 2024 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  63. Five-year outcomes of psilocybin-assisted therapy for Major Depressive Disorder
    Alan K. Davis, Meghan A. DellaCrosse, Nathan D. Sepeda, Adam W. Levin, Mary P Cosimano, Hillary Shaub, Taylor Washington, Peter M. Gooch, Shoval Gilead, Skylar J. Gaughan et al. · 2025 · Journal of Psychedelic Studies
  64. Feasibility and acceptability of a Whole-Body hyperthermia (WBH) protocol
    Ashley E. Mason, Sarah M. Fisher, Anoushka Chowdhary, Ekaterina V. Guvva, Danou Veasna, Erin G. Floyd, Sean B. Fender, Charles L. Raison · 2021 · International Journal of Hyperthermia
  65. Primary care-based screening and management of depression amongst heavy drinking patients: Interim secondary outcomes of a three-country quasi-experimental study in Latin America
    Amy Jane O'Donnell, Bernd Schulte, Jakob Manthey, Christiane Sybille Schmidt, Marina Piazza, Inés V. Bustamante, Guillermina Natera Rey, Natalia Bautista Aguilar, Graciela Yazmín Sánchez Hernández, Juliana Mejía‐Trujillo et al. · 2021 · PLoS ONE
  66. Examining the Use of Antidepressants for Adolescents with Depression/Anxiety Who Regularly Use Cannabis: A Narrative Review
    Danielle Hen-Shoval, Aron Weller, Abraham Weizman, Gal Shoval · 2022 · International Journal of Environmental Research and Public Health
  67. Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline
    Jia Huang, Yun Wang, Jun Chen, Yanlei Zhang, Zheng Yuan, Yue Li, Josep Maria Haro, María Victoria Moneta, Diego Novick, Yiru Fang · 2018 · Neuropsychiatric Disease and Treatment
  68. Offspring's own serotonin transporter genotype, independently from the maternal one, increases anxiety- and depression-like behavior and alters neuroplasticity markers in rats
    Menghan Sun, Paola Brivio, Ling Shan, Sylvia Docq, Lisa C.M.W. Heltzel, Celine A.J. Smits, Anthonieke Middelman, Roël M. Vrooman, Marcia Spoelder, Michel M. M. Verheij et al. · 2024 · Journal of Affective Disorders
  69. Synergistic use of deep TMS therapy with IV ketamine infusions for major depressive disorder: a pilot study
    Nathaniel A. Shanok, Sabrina Muzac, Leah Brown, Melissa Barrera, Raul Rodriguez · 2024 · Psychopharmacology
  70. Are we hallucinating or can psychedelic drugs modulate the immune system to control inflammation?
    Omar Qureshi, Jamie Cowley, Ashley Pegg, Alison J Cooper, John Gordon, Catherine Brady, Antonio Belli, Sam Butterworth, Rachel Upthegrove, Nick Andrews et al. · 2025 · British Journal of Pharmacology
  71. Advances of paeoniflorin in depression: the molecular mechanism and formula application
    Yiping Hou, Hongye Li, Luochen Zhu, Quan Tian, Xianhu Feng, Yue Li, Yuan Bian, Yuxun Wei · 2025 · Frontiers in Pharmacology
  72. Psilocybin with psychotherapeutic support for treatment-resistant depression: a pilot clinical trial
    Sally E Meikle, Olivia L. Carter, Paul Liknaitzky, Lauren Johansen, Ravi Iyer, Nigel H. M. Strauss, Martin L Williams, David Jonathan Castle, Susan Lee Rossell · 2025 · Therapeutic Advances in Psychopharmacology
  73. Key characteristics including sex, sexual orientation and internet use associated with worse mental health among university students in Brazil and implications
    Waléria de Paula, João Marcos Pereira, Nathália Sernizon Guimarães, Brian Godman, Renata Cristina Rezende Macedo do Nascimento, Adriana Lúcia Meireles · 2021 · Journal of Public Health
  74. Antidepressants escitalopram and venlafaxine up-regulate BDNF promoter IV but down-regulate neurite outgrowth in differentiating SH-SY5Y neurons
    Denis Zosen, Elena Kondratskaya, Oykum Kaplan‐Arabaci, Fred Haugen, Ragnhild E. Paulsen · 2023 · Neurochemistry International
  75. Global Research Trends and Hotspots Analysis of the Scientific Production of Amitriptyline: A Bibliometric Approach
    Cristian dos Santos Pereira, Jorddy Neves Cruz, Maria Karolina Martins Ferreira, Daiane Claydes Baia-da-Silva, Enéas Andrade Fontes-Júnior, Rafael Rodrigues Lima · 2023 · Pharmaceuticals
  76. Heart Rate Variability as a Potential Predictor of Response to Intranasal Esketamine in Patients with Treatment-Resistant Depression: A Preliminary Report
    Lorenzo Moccia, Giovanni Bartolucci, Maria Pepe, Ilaria Marcelli, Flavia Grisoni, Andrea Brugnami, Romina Caso, Francesca Bardi, Claudia Calderoni, Alessandro Michele Giannico et al. · 2024 · Journal of Clinical Medicine
  77. Review of the current ongoing clinical trials exploring the possible anti-anxiety effects of cannabidiol
    Rhenu Bhuller, Walter K. Schlage, Julia Hoeng · 2024 · Journal of Cannabis Research
  78. The Antidepressant Effect of Chlorella vulgaris on Female Wistar Rats (Rattus norvegicus Berkenhout, 1769) with Chronic Unpredictable Mild Stress Treatment
    Gisella Intan Soetantyo, Mulyati Sarto · 2019 · Journal of Tropical Biodiversity and Biotechnology
  79. Efficacy of hyperbaric oxygen combined with escitalopram in depression and its effect on cognitive function
    Kun Mi, Qiang Guo, Baoyan Xu, Man Wang, Hao Bi · 2021 · Pakistan Journal of Medical Sciences
  80. Psychopharmacoepidemiology of antidepressant medications among homeless and unstably housed service users in the Veterans Affairs healthcare system
    Jack Tsai, Dorota Szymkowiak, Theddeus Iheanacho · 2021 · Human Psychopharmacology Clinical and Experimental
  81. Common polygenic variation in the early medication change (EMC) cohort affects disorder risk, but not the antidepressant treatment response
    Svenja Müller, Klaus Lieb, Fabian Streit, Swapnil Awasthi, Stefanie Wagner, Josef Frank, Marianne B. Müller, André Tadić, Stefanie Heilmann‐Heimbach, Per Hoffmann et al. · 2024 · Journal of Affective Disorders
  82. Non-pharmacological treatment-related changes of molecular biomarkers in major depressive disorder: A systematic review and meta-analysis
    Courtney L. Irwin, Patrícia S. Coelho, Bruno Kluwe‐Schiavon, Anabela Silva‐Fernandes, Óscar F. Gonçalves, Jorge Leite, Sandra Carvalho · 2023 · International Journal of Clinical and Health Psychology
  83. Use of Quantile Treatment Effects Analysis to Describe Antidepressant Response in Randomized Clinical Trials Submitted to the US Food and Drug Administration
    William U. Meyerson, Carl F. Pieper, Rick H. Hoyle · 2023 · JAMA Network Open
  84. Antidepressants and fetal death: A systematic review and disproportionality analysis in the WHO safety database (VigiBaseⓇ)
    Pierre Desaunay, Maxime Eslier, Joachim Alexandre, Michel Dreyfus, Basile Chrétien, Fabian Guenolé · 2024 · Psychiatry Research
  85. Redefining Therapeutic Outcomes of Depression Treatment
    Christien Slofstra, Sanne Henrieke Booij, Rogier H. J. Hoenders, Stynke Castelein · 2019 · Journal for Person-Oriented Research
  86. Forty Years of Evidence on the Efficacy and Safety of Oral and Injectable Antibiotics for Treating Lyme Disease of Adults and Children: A Network Meta-Analysis
    Jiaru Yang, Shiyuan Wen, Jing Kong, Peng Yue, Wenjing Cao, Xin Xu, Yu Zhang, Jingjing Chen, Meixiao Liu, Yuxin Fan et al. · 2021 · Microbiology Spectrum
  87. Sertraline versus escitalopram in South Asians with moderate to severe major depressive disorder: (SOUTH-DEP) a double-blind, parallel, randomized controlled trial
    Sidra Raza, Saddique Ahmed, Rabia Islam, Muhammad Masroor Ahmed, Sandal Ashraf, Hamza Islam, Hifza Kiyani, Muhammad Saqib, Syed A. R. Shah, Hassan Mumtaz · 2023 · Annals of Medicine and Surgery
  88. Personality traits predict treatment outcome of an antidepressant in untreated adolescents with depression: An 8-week, open-label, flexible-dose study
    Liuyi Ran, Xinyi Liu, Wo Wang, Wanqing Tao, Jiao-Jiao Xiang, Qi Zeng, Yiting Kong, Chenyu Zhang, Jing Liao, Haitang Qiu et al. · 2024 · Journal of Affective Disorders
  89. A Real-World, Prospective, Multicenter, Single-Arm Observational Study of Duloxetine in Patients With Major Depressive Disorder or Generalized Anxiety Disorder
    G. Szekeres, S. Rózsa, P. Dome, G. Bársony, X. Gonda · 2021 · Frontiers in Psychiatry
  90. Learning the “Science of the Art of Prescribing”: From Evidence-based Algorithms to Individualized Medicine in Psychiatric Care
    Ian King, Yakov Shapiro · 2022 · Journal of Psychiatric Practice
  91. Evaluation of the clinical efficacy of Pediococcus acidilactici CCFM6432 in alleviating depression
    Peijun Tian, Hongyu Yang, Feng Hang, Gang Wang, Xuhua Mao, Xing Jin, Jianxin Zhao · 2024 · Microbiome Research Reports
  92. The effect of mitochondrial-associated endoplasmic reticulum membranes (MAMs) modulation: New insights into therapeutic targets for depression
    Maohui Yang, Xuemei Qin, Xiaojie Liu · 2025 · Neuroscience & Biobehavioral Reviews
  93. Step-by-step guide and checklists for selecting and conducting an evidence synthesis study using a framework for approaches and methods in evidence synthesis (FRAMES)
    Alok Kumar Dwivedi · 2026 · PeerJ
  94. Ketamine and other Glutamate Receptor Modulating Agents for Treatment-Resistant Depression: A Systematic Review of Randomized Controlled Trials
    Ahmad Shamabadi, Ali Ahmadzade, Ali Aqamolaei, Seyyed Hosein Mortazavi, Alireza Hasanzadeh, Shahin Akhondzadeh · 2022 · Iranian Journal of Psychiatry
  95. Treating depression in an outpatient setting: Predictors of patient response to bouldering psychotherapy, cognitive behavioural therapy or exercise alone
    Katharina Luttenberger, Carolin Donath, Elmar Graessel, Johannes Kornhuber, A. Schlüter, Lisa Dorscht, Leona Kind · 2023 · Clinical Psychology & Psychotherapy
  96. Supporting antidepressant discontinuation using mindfulness plus monitoring versus monitoring alone: A cluster randomized trial in general practice
    Marloes J. Huijbers, Carolien Wentink, Peter LBJ Lucassen, Cornelis Kramers, Reinier Akkermans, Jan Spijker, Anne E. M. Speckens · 2023 · PLoS ONE
  97. Investigation of Psychoactive Medications: Challenges and a Practical and Scalable New Path
    Dekel Taliaz, Alessandro Serretti · 2022 · CNS & Neurological Disorders - Drug Targets
  98. Psychiatry's Future: Biology, Psychology, Legislation, and “The Fierce Urgency of Now”
    Brendan D. Kelly · 2020 · Indian Journal of Psychological Medicine
  99. Psychological Issues and Care of Cancer Survivors
    Nienke Zomerdijk, Jane Turner · 2021 · Springer eBooks
  100. The efficacy and safety of acupuncture for patients with post-percutaneous coronary intervention depression
    Yong Liu, Disha Dai, Kai‐Lin Huang, Rui Zhuang, Liyong Ma, Birong Liu, Yi Pan, Lijing Zhang · 2020 · Medicine